Götz Münch

Title: Götz Münch: Innovator in Cardiovascular Research

Introduction

Götz Münch is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of cardiovascular research, particularly through his innovative patents. With a total of three patents to his name, Münch has focused on developing anti-thrombotic agents and related technologies.

Latest Patents

Münch's latest patents include groundbreaking inventions such as antibodies that bind to epitopes of glycoprotein VI. This invention provides anti-thrombotic agents, methods for screening these agents, and methods for treating thrombotic and other cardiovascular disorders. Another notable patent is an immunoadhesin comprising a glycoprotein VI domain. This fusion protein includes the extracellular domain of glycoprotein VI or a functional variant that binds to collagen, along with the Fc domain of immunoglobulin, characterized by a specific polypeptide chain.

Career Highlights

Throughout his career, Götz Münch has worked with several esteemed organizations. He has been associated with Trigen GmbH and Helmholtz Zentrum München, as well as the Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). His work in these institutions has furthered the understanding and treatment of cardiovascular diseases.

Collaborations

Münch has collaborated with notable colleagues in his field, including Meinrad Gawaz and Andreas Bültmann. These partnerships have contributed to the advancement of research and innovation in cardiovascular health.

Conclusion

Götz Münch's contributions to cardiovascular research through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field significantly, paving the way for future innovations in medical treatments.